THIS IS THE BLACK BOX WARNING THEY DIDN'T WANT YOU TO SEE

Pondimin and Redux are appetite suppressants, and appetite suppressants increase the risk of developing Primary Pulmonary Hypertension (PPH),an often fatal disease.

This site is designed to inform you about the health risks and legal rights concerning the use of the diet drugs Fen-Phen, Redux, and Pondimin.

"Fen-Phen" is a "word" that almost everyone has heard by now. "Fen-Phen" is shorthand for a diet drug combination of fenfluramine ("fen") and phentermine ("phen") that was heavily prescribed during the 1994-1997 time period. Another related diet drug that was also extensively prescribed beginning in 1996 is dexfenfluramine (marketed under the trade-name of Redux^TM).

Although originally approved for sale in the United States, fenfluramine and dexfenfluramine were withdrawn from the market in September 1997 after it was disclosed that there was a strong association between the use of those drugs and heart valve damage.

This site is designed to provide you with helpful information about these drugs, the medical problems associated with them, links to support groups and other information sources, and the legal ramifications resulting from the marketing and sale of these drugs. We hope that this information will help to answer your questions. If you need more information, however, please feel free to contact us.

ROBINSON, CALCAGNIE & ROBINSON
Santa Ana 888·348·8855	Newport Beach 949·720·1288	San Diego 619·338·4060